| | Tat-NR2B9c|500992-11-0 基本信息 更多信息 |
| 中文名称: | 500992-11-0 | | 中文同义词: | PSD95抑制剂(TAT-NR2B9C);H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-LYS-LEU-SER-SER-ILE-GLU-SER-ASP-VAL-OH;TAT-NR2B9C/NA-1;抑制剂多肽TAT-NR2B9C;(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S,50S,53S,59S)-59-氨基-38-(3-氨基-3-氧代丙基)-26,47,50-三(4-氨基丁基)-14-((S)-仲丁基)-11-(2-羧乙基)-5-(羧甲基)-29,32,35,41,44,53-六(3-胍丙基)-8,17,20-三(羟甲基)-60-(4-羟基苯基)-23-异丁基-2-异丙基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58-十九碳烷-3,6,9,12,15,18,21,24,27,;化合物 TAT-NR2B9C | | 英文名称: | Tat-NR2B9c | | 英文同义词: | Tat-NR2B9c;Tat-NR2B9c, >98%;L-Valine, L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-α-glutamyl-L-seryl-L-α-aspartyl-;Tat-NR2B9c/NA-1;500992-11-0/1834571-04-8;(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S,50S,53S,59S)-59-Amino-38-(3-amino-3-oxopropyl)-26,47,50-tris(4-aminobutyl)-14-((S)-sec-butyl)-11-(2-carboxyethyl)-5-(carboxymethyl)-29,32,35,41,44,53-hexakis(3-guanidinopropyl)-8,17,20-tris(hydroxymethyl)-60-(4-hydroxyphenyl)-23-isobutyl-2-isopropyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58-nonadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-nonadecaazahexacontanoic acid;Tat-NR2Bct|||NA-1 | | CAS号: | 500992-11-0 | | 分子式: | C105H188N42O30 | | 分子量: | 2518.88 | | EINECS号: | |  |
|
| 按国家浏览Tat-NR2B9c国外供应商 |
中国供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|